Cormorant Asset Management, LP's Form 4 filing
Bright Minds Biosciences Inc. (DRUG) · filed Apr 30, 2026
- Accession no.
- 0000929638-26-001708
- Filed
- Apr 30, 2026, 4:07 PM ET
- Trade date
- Apr 28, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $9.79M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cormorant Asset Management, LPCIK 0001583977 | Other: Former 10% Owner |
| Chen BihuaCIK 0001599214 | Other: Former 10% Owner |
| Cormorant Global Healthcare Master Fund, LPCIK 0001618442 | Other: Former 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | Common Shares | SSaleDisposed | −109,331 | $89.50 | −$9,785,124.5 | 950,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.